David Reese Selected Research

myelopoietin

10/2002

Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Reese Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 05/2004 - 08/2002
3	Neoplasms (Cancer) 04/2013 - 08/2002
1	Parkinson Disease (Parkinson's Disease) 04/2024
1	Movement Disorders (Movement Disorder) 01/2022
1	Liver Failure 01/2022
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Cough 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Lung Injury 01/2018
1	Bronchopneumonia 01/2018
1	Pneumothorax 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2010
1	Pleural Effusion (Pleural Effusions) 03/2010
1	Disease Progression 05/2004
1	Neutropenia 10/2002
1	Febrile Neutropenia 10/2002
1	Uterine Hemorrhage (Uterine Bleeding) 09/2002
1	Weight Gain 09/2002

Drug/Important Bio-Agent (IBA)

2	Carboplatin (JM8)FDA LinkGeneric 03/2010 - 05/2004
2	Trastuzumab (Herceptin)FDA Link 05/2004 - 08/2002
2	Docetaxel (Taxotere)FDA Link 05/2004 - 10/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2002 - 08/2002
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	IronIBA 01/2022
1	Monoclonal AntibodiesIBA 04/2013
1	Panitumumab (Vectibix)FDA Link 04/2013
1	ErbB Receptors (EGF Receptor)IBA 04/2013
1	Bevacizumab (Avastin)FDA Link 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2010
1	human TNFSF10 proteinIBA 03/2010
1	PlatinumIBA 05/2004
1	SaltsIBA 05/2004
1	Cisplatin (Platino)FDA LinkGeneric 05/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2002
1	myelopoietinIBA 10/2002
1	Filgrastim (Neupogen)FDA Link 10/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2002
1	leridistimIBA 10/2002
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 10/2002
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2002
1	EnzymesIBA 09/2002
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2002
1	Aromatase (CYP19)IBA 09/2002
1	Tamoxifen FDA LinkGeneric 09/2002
1	Anastrozole (Arimidex)FDA LinkGeneric 09/2002
1	AnthracyclinesIBA 08/2002
1	Proteins (Proteins, Gene)FDA Link 08/2002
1	Methotrexate (Mexate)FDA LinkGeneric 08/2002
1	Fluorouracil (Carac)FDA LinkGeneric 08/2002
1	Taxoids (Taxanes)IBA 08/2002

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 05/2004 - 08/2002
3	Therapeutics 10/2002 - 08/2002
1	Stents 01/2018
1	Molecular Targeted Therapy 08/2002